Email Newsletters

Health Care

House OKs Bill To Regulate Compounding Pharmacies

Nearly a year after a deadly national meningitis outbreak that originated at a Framingham pharmacy, the House on Wednesday unanimously approved legislation subjecting the industry to stricter oversight regulations and new licensing requirements.

Rehabilitative Resources CEO Resigns

Rehabilitative Resources Inc. CEO Michael Coughlin announced Friday that he will resign after nine months with the company.

In Reverse Decision, Sunovion Wins Patent Infringement Suit

A federal appellate court ruled last week that a planned generic sleep aid would infringe on Sunovion Pharmaceuticals Inc. patent for its Lunesta drug, rerversing a lower-court ruling against the Marlborough firm.

Successor To Long-Time CEO Could Dictate Waters’ Future

In the 18 years since Waters Corp. went public, other life sciences companies have expanded their product lines, made opportunistic acquisitions, merged and spun off new entities.
ADVERTISEMENT

Briefing: Physician Shortage

For eight years, the Massachusetts Medical Society (MMS) has been reporting a shortage of primary care physicians...

Health Reform Helps Launch Kennedy Center Ahead

About three years ago, the Edward M. Kennedy Community Health Center — which had just been renamed...

Ventilation Upgrades Slated For UMass Med Building

A Newton-based company announced Tuesday that it's been awarded a $1.2 million contract to install an air-quality monitoring system in University of Massachusetts Medical School laboratories.

UMass Memorial, Baystate Health Sign ‘Collaboration’ Deal

UMass Memorial Health Care is exploring potential “collaborative opportunities” with Springfield-based Baystate Health that could include clinical work, the Worcester-based health care system said today.
ADVERTISEMENT

State Prepping For Huge Shifts In Subsidized Insurance Populations

More than 150,000 people enrolled in the state's subsidized health insurance program Commonwealth Care will have three...

Cognoptix’s Alzheimer’s Test Yields Strong Results

Results from a clinical trial suggest that a Cognoptix eye test will be able to improve early diagnoses of Alzheimer's disease, according to the company.
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA